attia glp 1 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape GLP-Activate | Hunger & Metabolism

Rosenlund, J.W

10.1017/S1461145710000805 Int J Neuropsychopharmacol

Received: Revised: Accepted: Published: Issue date: DOI:

White AM, Johnston CS, Swan PD, Tjonn SL, Sears B: Blood ketones are directly related to fatigue and perceived effort during exercise in overweight adults adhering to low-carbohydrate diets for weight loss: a pilot study

[1] Causes of increased breakdown include genetic disorders such as sickle cell anemia, infections such as malaria, and certain autoimmune diseases like autoimmune hemolytic anemia

Clinical trials show that patients who continue GLP-1 therapy experience stable weight maintenance, while those who discontinue often see rapid weight return